Volume 1. No 3. Article 13

 Two views on the U.K. Dolk transmitter studies

Quoting from Senator Richard Alston, Minister for Communications and the Arts, Senate speech of 5 March 1997 attacking Dr. Neil Cherry:

 

"The facts are that the United Kingdom department of health recently published a national study which concluded that people living close to radio or television transmitting masts are not at increased risk of developing leukemia. Dr Cherry simply refuses to take notice of that. This man is not interested in the facts."

Comments on Senator Alston's statement by Professor Ivan Beale. Dr. Beale is a committee member on the joint Australian/New Zealand Standards Committee for the current RF/MW standard AS 2772-1 1990. Dr. Beale's reply (5/3/97):

"The UK study referred to by Senator Alston was not published by the UK Department of Health. In fact there are two studies, not one. The authors are Dolk et al., and both are published in the American Journal of Epidemiology, vol 145, 1997. In fact, both studies found a decline in risk with increasing distance from a transmitter, for adult leukemia. Additionally, one study (Sutton Coldfield) found an significantly elevated risk for adult leukemia within 2 km of the transmitter, whereas the other study (multiple sites) did not. These findings seem inconsistent with the Senator's statement.

"Several of Senator Alston's statements could be fairly summarised as saying something like this:" the responsible science-based view is that there is no scientific evidence that radiofrequency radiation associated with telecommunications and broadcasting places the public at risk for adverse health effects.

"My comment is this: Any competent literature review would conclude that there is substantial evidence of biological effects in animals and cell cultures and of adverse health effects in humans, of exposure to RF fields too weak to produce significant heating. Protection standards have not been based on this evidence because it is not yet sufficiently coherent to yield thresholds for adverse effects. In my view it is irresponsible to say that this evidence is unscientific or unsubstantiated, and it is irresponsible to say that this evidence proves that the public are at risk.

"What is responsible, is to say that there is legitimate reason for concern, and that we should adopt a precautionary approach until such time as the evidence is more coherent. It's a pity that the debate reported in this Hansard was not more responsible and balanced in its consideration of this issue."